BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Posts with tag Pharmaceuticals

Sort by Latest
Singapore Gets Vaccinated! Introduction of the Pandemic Special Access Route (PSAR) for COVID-19 vaccines, therapeutic products and medical devices
As part of a slew of measures to mitigate the effect of the COVID-19 pandemic in Singapore, the Health Sciences Authority (HSA) recently rolled out the Pandemic Special Access Route (PSAR) to facilitate early access to critical health products needed for the treatment and/or prevention of infectious diseases like COVID-19. Eligible health products may be granted interim authorisation for manufacture, import and supply in Singapore even before registration, while continuous evaluation...
March 25, 2021
6 min read
Chinese patent linkage system – the Chinese Supreme...
The Chinese Supreme Court (“SPC”) released on...
November 13, 2020
6 min read
Australian Courts apply “European Support” test to...
In the recent decision in the Australian front of the...
November 4, 2020
10 min read
French Healthtech in the Covid crisis: when strategic...
The strategic challenges of the French Healthtech sector - health,...
October 13, 2020
6 min read
Increased Leeway for Cooperation between Pharma and Medical Equipment Companies during the Covid-19 Crisis
Competition rules are aimed at safeguarding healthy competition between companies. For more than half...
April 9, 2020
7 min read
German Constitutional Court declares the vote on the ratification act of the UPC Agreement unconstitutional because of a lack of the required quorum
Today the German Constitutional Court (Bundesverfassungsgericht) ruled that the German ratification...
March 20, 2020
5 min read
SPCs For Second Medical Use Products – Is There an End in Sight?
Over the years, pharmaceutical companies have obtained Supplementary Protection Certificates (SPCs) for...
February 24, 2020
6 min read
Badmouthing Your Competitor’s Products: When Does Denigration Become an Antitrust Issue?
Over the past decade, different competition authorities across Europe have begun to identify and pursue...
February 20, 2020
25 min read
The US/China Trade Agreement: what could it mean for the Pharma Industry?
Following a long period of negotiation, Phase I of the US-China Trade Agreement was published on 15 January...
February 6, 2020
5 min read
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publication and prior use.
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss...
November 19, 2019
5 min read
12
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.